Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer
- PMID: 9667653
- PMCID: PMC2150318
- DOI: 10.1038/bjc.1998.303
Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer
Abstract
The synthesis and degradation of type I and type III interstitial collagens releases several antigenic metabolites, whose measurement allows the metabolism of connective tissue to be evaluated under a variety of different conditions. In this study we investigated the influence of benign and malignant ovarian neoplasms on the metabolism of these collagens. The study population comprised patients with benign (n = 53), borderline (n = 6) or malignant (n = 36) ovarian neoplasms. We quantified the serum, cyst fluid and peritoneal/ascitic fluid concentrations of the amino-terminal propeptide of type I (PINP) and III (PIIINP) procollagens, indicators of the synthesis of type I and III collagen, respectively and the cross-linked carboxy-terminal telopeptide of type I collagen (ICTP), an indicator of type I collagen degradation. Macrophage colony-stimulating factor 1 (CSF-1) concentration was also assayed as its serum level is increased in ovarian cancer and CSF-1 may be involved in the regulation of collagen metabolism. The concentration of each antigen was significantly higher in patients with malignant tumour than with benign neoplasm in each comparison, except for ICTP in peritoneal fluid and for CSF-1 in cyst fluid. The high ascitic fluid concentration of PINP, PIIINP or CSF-1 correlated with malignancy, and the low cyst fluid concentration of any of the four markers was indicative of benign tumour. Levels of CSF-1 did not correlate with the levels of any of the markers of collagen turnover. The concentration of PINP in ascites was about 50 times higher and in cyst fluid about eight times higher than that in the serum from patients with malignant tumour, whereas the respective ratios for ICTP were only 2.5 and 1.3. In such patients, the ratio of ascitic fluid to serum concentration was also about 80-fold higher for PIIINP and about 20-fold higher for PINP than for ICTP. The different distributions of PIIINP, PINP and ICTP suggests dominance of synthetic processes or retarded elimination of PIIINP and PINP in ovarian cancer. In advanced malignancies, the accumulation of PINP and PIIINP in abdominal space, possibly due to increased synthesis and/or failed resorption, may promote ascites formation. This study shows that both accelerated synthesis and breakdown of fibrillar collagens are characteristic of ovarian malignancy, and suggests that measurements of cyst fluid or ascitic fluid concentrations of collagen metabolites or CSF-1 could be used in the differential diagnosis of benign and malignant ovarian neoplasms.
Similar articles
-
Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.J Bone Miner Res. 1998 Apr;13(4):731-8. doi: 10.1359/jbmr.1998.13.4.731. J Bone Miner Res. 1998. PMID: 9580479
-
Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis.Ann Rheum Dis. 1995 Nov;54(11):886-90. doi: 10.1136/ard.54.11.886. Ann Rheum Dis. 1995. PMID: 7492237 Free PMC article.
-
Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis.Clin Chem Lab Med. 2003 Aug;41(8):1038-44. doi: 10.1515/CCLM.2003.160. Clin Chem Lab Med. 2003. PMID: 12964811
-
Aminoterminal propeptide of type III procollagen in ovarian cancer. A review.Acta Obstet Gynecol Scand Suppl. 1992;155:99-103. doi: 10.1111/j.1600-0412.1992.tb00014.x. Acta Obstet Gynecol Scand Suppl. 1992. PMID: 1502898 Review.
-
Procollagen assays in cancer.Adv Clin Chem. 2014;66:79-100. doi: 10.1016/b978-0-12-801401-1.00003-7. Adv Clin Chem. 2014. PMID: 25344986 Review.
Cited by
-
UFFizi: a generic platform for ranking informative features.BMC Bioinformatics. 2010 Jun 3;11:300. doi: 10.1186/1471-2105-11-300. BMC Bioinformatics. 2010. PMID: 20525252 Free PMC article.
-
Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers.Thorac Cancer. 2019 Feb;10(2):277-288. doi: 10.1111/1759-7714.12947. Epub 2019 Jan 3. Thorac Cancer. 2019. PMID: 30604926 Free PMC article.
-
Integrin regulation of beta-catenin signaling in ovarian carcinoma.J Biol Chem. 2011 Jul 1;286(26):23467-75. doi: 10.1074/jbc.M110.199539. Epub 2011 Apr 25. J Biol Chem. 2011. PMID: 21518759 Free PMC article.
-
A comparative analysis of different biofluids towards ovarian cancer diagnosis using Raman microspectroscopy.Anal Bioanal Chem. 2021 Jan;413(3):911-922. doi: 10.1007/s00216-020-03045-1. Epub 2020 Nov 26. Anal Bioanal Chem. 2021. PMID: 33242117 Free PMC article.
-
Differential gene expression in ovarian carcinoma: identification of potential biomarkers.Am J Pathol. 2004 Aug;165(2):397-414. doi: 10.1016/S0002-9440(10)63306-8. Am J Pathol. 2004. PMID: 15277215 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous